-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Ambrx Biopharma, Inc. quarterly Operating Lease, Payments history and growth rate from Q3 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $701K, a 1.74% increase year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)